<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The results of preliminary clinical trial (a multicenter, open-label, dose escalation study) of intrathecal recombinant tissue plasminogen activator (rt-PA) for the prevention of <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> were reported </plain></SENT>
<SENT sid="1" pm="."><plain>Seventeen patients admitted within 48 hours of <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) were enrolled in this study </plain></SENT>
<SENT sid="2" pm="."><plain>Patients ranged from 42 to 69 years of age </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases enrolled were classified in clinical grade II, III or IV according to the classification of Hunt and Kosnik and in group 3 or 4 according to Fisher's CT grading scale </plain></SENT>
<SENT sid="4" pm="."><plain>Surgery for clipping the <z:hpo ids='HP_0002617'>aneurysms</z:hpo> were performed and a small <z:chebi fb="144" ids="48140">silicone</z:chebi> catheter was left in the subarachnoid space </plain></SENT>
<SENT sid="5" pm="."><plain>Twenty four hours after the surgery intrathecal bolus infusion of rt-PA was started through the <z:chebi fb="144" ids="48140">silicone</z:chebi> catheter at 6-hour intervals for 3 days </plain></SENT>
<SENT sid="6" pm="."><plain>Patients were divided into 4 groups based on the dosage of rt-PA for each infusion </plain></SENT>
<SENT sid="7" pm="."><plain>The dosage of rt-PA for each infusion and a number of cases in each group was as follows; 25 KIU in 4 cases, 75 KIU in 6 cases, 200 KIU in 4 cases and 600 KIU in 3 cases </plain></SENT>
<SENT sid="8" pm="."><plain>There was no significant difference in the clearance of subarachnoid clots between four groups </plain></SENT>
<SENT sid="9" pm="."><plain>However, the occurrence of both symptomatic and angiographic vasospasm was less in the 75 KIU group than in other three groups </plain></SENT>
<SENT sid="10" pm="."><plain><z:mp ids='MP_0001915'>Intracranial bleeding</z:mp> complications were noted in 4 patients (1/6 in the 75 KIU group, 2/4 in the 200 KIU group and 1/3 in the 600 KIU group) </plain></SENT>
<SENT sid="11" pm="."><plain>Serial coagulation studies demonstrated no evidence of systemic fibrinolysis </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0001289'>Disorientation</z:hpo> was noted in 2 out of 3 patients of the 600 KIU group.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>